1-year old Vaccines – Varicella

Get Your Patient Form
7110 Forest Ave, Suite 201 Richmond, VA 23226
804-250-9859
Get Your Patient Form
Summary
Clinical Research Partners is enrolling healthy children ages 12–15 months for the Lullaby-002 Study, which is evaluating an investigational vaccine designed to help prevent chickenpox. The study will assess the safety of the study vaccine compared with an approved chickenpox vaccine.
Age
12-15 months
Qualifications
  • Healthy children ages 12–15 months
  • Have not had chickenpox
  • Have not been vaccinated against chickenpox
  • Have not been vaccinated against measles, mumps, and rubella
  • Have not been vaccinated against hepatitis A
  • Are not currently participating in another clinical study
  • Additional eligibility criteria apply

Meet Our Team

Our experienced team will guide you through the process

Meet the Team

Dr. Call, co-founder of Clinical Research Partners, serves as President. He is a Certified Principle Investigator

Robert S. Call, MD, CPI

President

Annette Bennett, co-founder of Clinical Research Partners, serves as Chief Executive Officer and Research Director. She

Annette Bennett

Chief Executive Officer

Bo Vaughan is a native of Richmond, VA and forward-thinking health care strategist with a

Bo Vaughan, MD, MSHA, CPI

Medical Director

Mimi Franzen Canada

Chief Operations Officer

Jeanette Weller

EVP of Contracts and Budgets

Caitlin Vining

Controller CCRP

Kelly Craighead, BS, RN, CCRC

Regulatory Affairs Director

Carly McLaughlin, PharmD

Director of Pharmacy PharmD

Lisa Smith, BSN, RN

Director of Quality Assurance

Joy Walker

Director of Business Development

Aundraya Bray, LCSW

Clinical Operations Coordinator

Shawn Mease, CCRC, NRP, CCEMT-P

Director of Study Start-Up